XML 67 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Compensation Related Costs [Abstract]  
Schedule of Stockholders' Deficit
The following tables present certain information regarding our stockholders’ equity as of September 30, 2023 and 2022:
Nine Months Ended September 30, 2023
Common StockAdditional Paid in CapitalRetained EarningsTreasury StockAccumulated Other Comprehensive LossNoncontrolling InterestTotal
January 1, 2023$$1,370 $517 $(580)$(318)$171 $1,161 
Settlement of liability awards— 25 — — — — 25 
Vesting of RSUs, net of tax withholdings and other— (14)— — — — (14)
Purchase of treasury stock— — — (28)— — (28)
Purchase of SciPlay’s Class A common stock— (8)— — — — (8)
Stock-based compensation— 15 — — — — 15 
Net income— — 22 — — 27 
Other comprehensive income— — — — — 
March 31, 2023$$1,388 $539 $(608)$(312)$176 $1,184 
Vesting of RSUs, net of tax withholdings and other— — — — — 
Purchase of treasury stock— — — (5)— — (5)
Purchase of SciPlay’s Class A common stock— (15)— — — — (15)
Stock-based compensation— 13 — — — — 13 
Net (loss) income— — (1)— — 
Other comprehensive income— — — — 47 — 47 
June 30, 2023$$1,387 $538 $(613)$(265)$182 $1,230 
Vesting of RSUs, net of tax withholdings and other— — — — — 
Purchase of treasury stock(1)
— — — (113)— — (113)
Stock-based compensation— 12 — — — — 12 
Net income— — 75 — — 80 
Other comprehensive loss— — — — (66)— (66)
September 30, 2023$$1,402 $613 $(726)$(331)$187 $1,146 
(1) Includes excise taxes of $1 million for the three and nine months ended September 30, 2023.
Nine Months Ended September 30, 2022
 Common StockAdditional Paid in CapitalRetained Earnings (Accumulated Loss)Treasury StockAccumulated Other Comprehensive LossNoncontrolling InterestTotal
January 1, 2022$$1,337 $(3,158)$(175)$(261)$150 $(2,106)
Settlement of liability awards— 43 — — — — 43 
Vesting of RSUs, net of tax withholdings and other— (31)— — — — (31)
Purchase of treasury stock— — — (51)— — (51)
Stock-based compensation— 17 — — — — 17 
Net income— — 26 — — 28 
Other comprehensive loss— — — — (37)— (37)
March 31, 2022$$1,366 $(3,132)$(226)$(298)$152 $(2,137)
Vesting of RSUs, net of tax withholdings and other— — — — — — — 
Purchase of treasury stock— — — (152)— — (152)
Purchase of SciPlay’s Class A common stock— (6)— — — (1)(7)
Stock-based compensation— 15 — — — — 15 
Net income— — 3,291 — — 3,295 
Other comprehensive loss(1)
— — — — (48)— (48)
June 30, 2022$$1,375 $159 $(378)$(346)$155 $966 
Vesting of RSUs, net of tax withholdings and other— (3)— — — — (3)
Purchase of SciPlay’s Class A common stock(10)(1)(11)
Stock-based compensation— 14 — — — — 14 
Net income— — 328 — — 335 
Other comprehensive loss(1)
— — — — (69)— (69)
September 30, 2022$$1,376 $487 $(378)$(415)$161 $1,232 
(1) Includes reclassifications of $51 million and $74 million for the three and nine months ended September 30, 2022, respectively, from accumulated other comprehensive loss into income due to the sales of discontinued operations (see Note 2).
Schedule of Stock-based Compensation Expense Recognized
The following reflects total stock-based compensation expense recognized under all programs:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Related to L&W stock options$— $— $— $
Related to L&W RSUs19 12 59 39 
Related to SciPlay RSUs12 26 
Total(1)
$31 $15 $85 $47 
(1) Includes $19 million and $45 million classified as liability awards for the three and nine months ended September 30, 2023, respectively, and $6 million and $16 million for the three and nine months ended September 30, 2022, respectively.
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
A summary of the changes in RSUs outstanding under our equity-based compensation plans during the nine months ended September 30, 2023 is presented below:
Number of Restricted Stock UnitsWeighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2022
1.7 $46.66 
Granted1.1 $57.54 
Vested(1.0)$44.52 
Cancelled(0.1)$50.43 
Unvested RSUs as of September 30, 2023
1.7 $54.66